# Chase Brexton Health Services, Inc

Health Center, MD
Page: https://astrelis.co/providers/health_center/211819  
This twin: https://astrelis.co/providers/health_center/211819.md  
CMS Certification Number (CCN): 211819  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 48,106. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 147,873. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 7. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 35.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -6.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $156.0M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +7.9%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Chase Brexton Health Services, Inc., MD

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state (FACLAND tier 1)).

- FY ending 2025-06-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000390145
- FY ending 2024-06-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000065696
- FY ending 2023-06-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000004040

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 10,132,016 [derived, p.5] | 6,940,140 [derived, p.5] | 7,644,722 [derived, p.5] |
| patient receivables, net (Statement of financial position) | 10,781,359 [derived, p.5] | 9,856,135 [derived, p.5] | 7,293,323 [derived, p.5] |
| grants and other receivables (Statement of financial position) | 2,938,321 [derived, p.5] | 2,882,064 [derived, p.5] | 2,639,927 [derived, p.5] |
| other current assets (Statement of financial position) | 4,158,453 [derived, p.5] | 3,548,489 [derived, p.5] | 3,636,695 [derived, p.5] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 28,010,149 [extracted, p.5] | 23,226,828 [extracted, p.5] | 21,214,667 [extracted, p.5] |
| property and equipment, net (Statement of financial position) | 25,632,770 [derived, p.5] | 27,064,630 [derived, p.5] | 26,730,383 [derived, p.5] |
| other long-term assets (Statement of financial position) | 109,305,885 [derived, p.5] | 100,919,509 [derived, p.5] | 91,322,943 [derived, p.5] |
| TOTAL ASSETS (Statement of financial position) | 162,948,804 [extracted, p.5] | 151,210,967 [extracted, p.5] | 139,267,993 [extracted, p.5] |
| payables and accrued expenses (Statement of financial position) | 13,973,899 [derived, p.6] | 11,835,181 [derived, p.6] | 10,836,339 [derived, p.6] |
| deferred revenue (Statement of financial position) | 166,361 [derived, p.6] | 790,069 [derived, p.6] | 525,255 [derived, p.6] |
| current debt and leases (Statement of financial position) | 1,674,394 [derived, p.6] | 1,580,201 [derived, p.6] | 1,388,145 [derived, p.6] |
| other current liabilities (Statement of financial position) | 441,158 [derived, p.6] | 458,817 [derived, p.6] | 495,350 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 16,255,812 [extracted, p.6] | 14,664,268 [extracted, p.6] | 13,245,089 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 8,816,701 [derived, p.6] | 10,398,966 [derived, p.6] | 11,638,896 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 294,939 [derived, p.6] | 237,674 [derived, p.6] | 177,101 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 25,367,452 [extracted, p.6] | 25,300,908 [extracted, p.6] | 25,061,086 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 136,474,117 [derived, p.6] | 124,406,481 [derived, p.6] | 113,070,220 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 1,107,235 [derived, p.6] | 1,503,578 [derived, p.6] | 1,136,687 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 137,581,352 [extracted, p.6] | 125,910,059 [extracted, p.6] | 114,206,907 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 155,962,494 [derived, p.7] | 142,818,335 [derived, p.7] | 125,873,118 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 8,974,972 [derived, p.7] | 9,114,300 [derived, p.7] | 11,946,624 [derived, p.7] |
| contributions (Statement of activities) | 684,727 [derived, p.7] | 1,226,473 [derived, p.7] | 201,728 [derived, p.7] |
| other revenue (Statement of activities) | 1,839,154 [derived, p.7] | 906,613 [derived, p.7] | 806,181 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 167,461,347 [extracted, p.7] | 154,065,721 [extracted, p.7] | 138,827,651 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 62,657,044 [derived, p.7] | 58,630,074 [derived, p.7] | 51,489,970 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 96,663,866 [derived, p.7] | 88,375,245 [derived, p.7] | 76,824,968 [derived, p.7] |
| purchased and professional services (Statement of activities) | 1,799,291 [derived, p.7] | 1,487,012 [derived, p.7] | 1,804,212 [derived, p.7] |
| occupancy (Statement of activities) | 2,588,430 [derived, p.7] | 2,346,672 [derived, p.7] | 2,269,623 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 4,363,152 [derived, p.7] | 3,996,188 [derived, p.7] | 4,053,650 [derived, p.7] |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | absent (not printed, or not read) | 1,831,002 [derived, p.7] | 1,456,202 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 168,071,783 [extracted, p.7] | 156,666,193 [extracted, p.7] | 137,898,625 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -610,436 [extracted, p.7] | -2,600,472 [extracted, p.7] | 929,026 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 12,281,729 [derived] | 14,303,624 [derived] | 10,659,167 [derived] |
| CHANGE IN NET ASSETS (Statement of activities) | 11,671,293 [extracted, p.8] | 11,703,152 [extracted, p.8] | 11,588,193 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 125,910,059 [extracted, p.8] | 114,206,907 [extracted, p.8] | 102,618,714 [extracted, p.8] |
| net assets, end (Statement of activities) | 137,581,352 [extracted, p.8] | 125,910,059 [extracted, p.8] | 114,206,907 [extracted, p.8] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 23 days [plausible] | 17 days [plausible] | 21 days [plausible] |
| Current ratio | 1.72x [plausible] | 1.58x [plausible] | 1.60x [plausible] |
| Operating margin | -0.4% [plausible] | -1.7% [plausible] | 0.7% [plausible] |
| Total margin | 7.0% [plausible] | 7.6% [plausible] | 8.3% [plausible] |
| Patient revenue share | 93.1% [plausible] | 92.7% [plausible] | 90.7% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 37.3% [plausible] | 37.4% [plausible] | 37.3% [plausible] |
| Days in patient receivables | 25 days [plausible] | 25 days [plausible] | 21 days [plausible] |
| Debt to net assets | 0.08x [plausible] | 0.10x [plausible] | 0.11x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Chase Brexton Health Services, Inc.; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Chase Brexton Health Services, Inc", https://astrelis.co/providers/health_center/211819, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.